1. |
Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases:structure, function, and biochemistry[J]. Circ Res, 2003, 92(8):827-839.
|
2. |
Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis:the good, the bad, and the ugly[J]. Circ Res, 2002, 90(3):251-262.
|
3. |
Jacob-Ferreira AL, Schulz R. Activation of intracellular matrix metalloproteinase-2 by reactive oxygen-nitrogen species:consequences and therapeutic strategies in the heart[J]. Arch Biochem Biophys, 2013, 540(1/2):82-93.
|
4. |
Horstmann S, Kalb P, Koziol J, et al. Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients:influence of different therapies[J]. Stroke, 2003, 34(9):2165-2170.
|
5. |
Montaner J, Molina CA, Monasterio J, et al. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke[J]. Circulation, 2003, 107(4):598-603.
|
6. |
全国第四届脑血管病学术会议. 脑卒中患者临床神经功能损伤程度评分标准及临床疗效评定标准[J]. 中华神经科杂志, 1996, 29(6):381-383.
|
7. |
王新, 黄如训, 曾进胜. 脑梗死急性期血清MMP-9的动态变化及其与脑梗死分型关系的研究[J]. 中国神经精神疾病杂志, 2005, 31(1):20-23.
|
8. |
周进. MMP-2及MMP-9在缺血再灌注大鼠脑中的表达及意义[J]. 辽宁医学杂志, 2005, 19(4):175-176.
|
9. |
Akamatsu Y, Saito A, Fujimura M, et al. Stachybotrys microspora triprenyl phenol-7, a novel fibrinolytic agent, suppresses superoxide production, matrix metalloproteinase-9 expression, and thereby attenuates ischemia/reperfusion injury in rat brain[J]. Neurosci Lett, 2011, 503(2):110-114.
|
10. |
Brouns R, Wauters A, De Surgeloose D, et al. Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and outcome[J]. Eur Neurol, 2011, 65(1):23-31.
|
11. |
陈红兵, 郭云良, 孙圣刚, 等. 大鼠脑缺血再灌流后基质金属蛋白酶2和9的表达[J]. 解剖学杂志, 2005, 28(3):304-307.
|
12. |
Chang DI, Hosomi N, Lucero J, et al. Activation systems for latent matrix metalloproteinase-2 are upregulated immediately after focal cerebral ischemia[J]. J Cereb Blood Flow Metab, 2003, 23(12):1408-1419.
|
13. |
Magnoni S, Baker A, George SJ, et al. Differential alterations in the expression and activity of matrix metalloproteinases 2 and 9 after transient cerebral ischemia in mice[J]. Neurobiol Dis, 2004, 17(2):188-197.
|
14. |
Guo M, Cox B, Mahale S, et al. Pre-ischemic exercise reduces matrix metalloproteinase-9 expression and ameliorates blood-brain barrier dysfunction in stroke[J]. Neuroscience, 2008, 151(2):340-351.
|
15. |
Brouns R, Wauters A, De Surgeloose D, et al. Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and outcome[J]. Eur Neurol, 2011, 65(1):23-31.
|
16. |
张建平, 孟凡超, 代吉文, 等. 局部亚低温干预对实验大鼠脑出血后MMP-2/9表达及脑水肿的影响[J]. 中华物理医学与康复杂志, 2007, 29(10):649-652.
|
17. |
陶定波, 姜秀丽, 雷阳, 等. 急性期脑梗死患者血清MMP-9水平动态变化意义及与预后的关系[J]. 中风与神经疾病杂志, 2009, 26(2):176-179.
|
18. |
陶晶, 李志, 刘卉萍. 急性脑梗死患者血清基质金属蛋白酶-9检测的临床意义[J]. 实用医技杂志, 2011, 18(12):1243-1245.
|